STAT3 and glioblastoma: OSMR, characterized as a novel key regulator of glioblastoma tumorigenesis through EGFRvIII-STAT3 signaling, also correlates with poor prognosis in GBM patients both independently and also as part of a 4-gene signature (71,74).